Sarah Hughes to Drug Hypersensitivity
This is a "connection" page, showing publications Sarah Hughes has written about Drug Hypersensitivity.
Connection Strength
0.363
-
Hughes S, Hughes A, Brothers C, Spreen W, Thorborn D. PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events. Pharm Stat. 2008 Apr-Jun; 7(2):121-9.
Score: 0.291
-
Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, J?gel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008 Feb 07; 358(6):568-79.
Score: 0.072